Death due to Covid-19 in a Patient with Diabetes, Epilepsy, and Gout
comorbidities
- Amir Reza Safdarian,
- Kaveh Momenzadeh
, - Farima Kahe,
- Pooya Farhangnia,
- nima rezaei
Abstract
There is evidence of increased incidence, rapid progression, and poor
prognosis of Covid-19 in patients with underlying comorbidities such as
diabetes and epilepsy. It is crucial to develop effective treatment
regimens for these patients. Multiple organ failure is the most common
cause of death in Covid-19 patients.16 Sep 2020Submitted to Clinical Case Reports 19 Sep 2020Submission Checks Completed
19 Sep 2020Assigned to Editor
06 Oct 2020Reviewer(s) Assigned
13 Oct 2020Review(s) Completed, Editorial Evaluation Pending
16 Oct 2020Editorial Decision: Revise Minor
21 Oct 20201st Revision Received
22 Oct 2020Submission Checks Completed
22 Oct 2020Assigned to Editor
22 Oct 2020Review(s) Completed, Editorial Evaluation Pending
01 Nov 2020Editorial Decision: Accept
Jan 2021Published in Clinical Case Reports volume 9 issue 1 on pages 461-464. 10.1002/ccr3.3557 
